FDA Approval to Proceed with Phase I of the Mistletoe Clinical Trial! Believe Big
We received the wonderful news that we have been approved by the FDA to proceed with Phase I of the Mistletoe Clinical Trial at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center!
THIS IS HUGE!! You should have heard the “Woo Hoo’s” and seen the celebration when we received the good news! This is an amazing accomplishment for all of us and especially for the cancer patients who will benefit from the IV Mistletoe therapy. We have truly experienced God’s favor! Thank you for your prayers; God has certainly answered them!
So what happens next?
We have just one more step before we can begin to enroll patients in the trial. Johns Hopkins internal review board will now need to look over all
aspects of the trial in order to give us the green light to begin. We have been told that this process may take a two to three months. For those interested in participating in the trial, if you haven’t done so already, please subscribe to our eNewsletter at
We will be sending an email out when we hear from Johns Hopkins that patients can enroll in the trial.
Who can enroll?
All solid tumor types who have had one line of conventional therapy and are stage 4.
Please continue to pray for the trial, the patients, and for the remaining funds needed to complete the trial. Thanks to an anonymous donor, we were able to match gifts at the end of December and raise over $62,000 for phase 1 of the trial! We are so close and only need $105,000 more! We can do this!